Team Member
Senior Advisor
Areas of Focus:
- Healthcare
Mr. Van Hulst has 39 years experience in the pharmaceutical industry, having served as EVP of Mova Pharmaceutical Corporation, a dosage form manufacturer; owner and CEO of two generic pharmaceutical companies; and President of Diosynth. He is Director of Hi-Tech Pharmacal, Napo Pharmaceuticals, and Senesco Technologies and a former director of Protein Sciences.
| Operating Committee |
| Carty Chock |
| Jeffrey Kovach |
| Joelle Marquis |
| Stephen Mclean |
| Terrence Mullen |
| Cengiz Selman |
| John Televantos |
| Timothy Zappala |
| Operating Professionals |
| Mary Driscoll |
| William Stuckey |
| Vlad Walko |
| Alan Weber |
| Simon Baitler |
| Stanley Bikulege |
| Tad Dwyer |
| Anthony Giorgio |
| Susan Hay |
| William Hernandez |
| Andrew Thompson |
| Paul Westgate |
| Senior Advisors |
| James Bannon |
| Martyn Greenacre |
| Roger Harrison |
| Scott Hayworth |
| William Himmelsbach |
| Neil Krauter |
| Demetrios ("Demi") Lappas |
| Steve Li |
| Praveen Tyle |
| Investment Professionals |
| Eugene Gorbach |
| Chee We Ng |
| Eric Geveda |
| Jeff Moffett |
| Roy Seroussi |
| Elana Caplan |
| Wendy Ding |
| Joseph Rooney |
| Finance Professionals |
| Pilar Lorente |